Podcast: Here's what innovators think of Houston's innovation ecosystem

HOUSTON INNOVATORS PODCAST EPISODE 175

This week's episode of the Houston Innovators Podcast features five mini interviews with Houston innovators. Photos courtesy

It's the fourth year for Houston Tech Rodeo — a four-day event that takes over Houston's innovation ecosystem — and the programming is in full swing.

The week, put on by Houston Exponential, shines a spotlight on Houston innovators, investors, startup development organizations, and more and invites everyone to the table to learn more about the goings on within Houston's business community and connect with fellow Houstonians.

In honor of the week, today's edition of the Houston Innovators Podcast is a bit different. Rather than sit down with one Houston innovator, I got to chat briefly with five movers and shakers within Houston tech: Damyanna Cooke of Boozed and the Black Founders Network,Joshua Taylor of Capital Factory and the Black Founders Network,LaGina Harris of The US Space,Brandy Guidry of the Pearland Innovation Hub, and Chad Spensky of Allthenticate.

I took the opportunity to ask each of them about how they have engaged with the Houston innovation ecosystem and how they've seen it evolve and grow. Each of them also told me what they thought the city still needed to work on as well as its greatest asset to founders and the greater innovation community.

Listen to the interview below — or wherever you stream your podcasts — and subscribe for weekly episodes.


This tech company wants to replace passwords for good. Photo courtesy of Allthenticate

Tech startup closes seed round at over $3M, plans to grow Houston team

money moves

A California-founded company that recently put down roots in Houston has announced the closing of its seed round of funding.

Allthenticate, a tech startup that enables unified authentication, announced over $3 million raised in its seed funding round led by Austin-based Silverton Partners with participation from California-based Amplify and Denver-based Ping Identity. The total raised in the round is $3,133,337, which, as the press release explains, translates to “elite” in hacker speak.

Allthenticate’s technology and services allow users to utilize smartphone devices to unlock and log in to everything — from doors to computers and servers. The company's mission is to provide safe, easy-to-use security infrastructure for everyday use and to target small- to medium-sized businesses to deploy the technology across their workforces.

“The Internet desperately needs an authentication overhaul," says Chad Spensky, founder and CEO of the company, in the release. "Our current ecosystem is cumbersome, limits innovation, and has numerous security shortcomings. I have dedicated my career to this problem and feel very fortunate to have the support to continue to develop our technology and bring it to the masses.

"The feedback from our early customers has been incredibly positive, which is only compounding the excitement here at Allthenticate," he continues.

Chad Spensky is based in Houston and offices out of The Ion. Photo courtesy of Allthenticate

Allthenticate, which Spensky co-founded with Rita Mounir in 2019 in Santa Barbara, licensed its core technology from MIT that was originally developed for the Department of Defense by Spensky and his team during their tenure at MIT Lincoln Laboratory.

"Silverton has a long history of working with leaders who have pushed boundaries in identity, governance, and access management," says Silverton’s managing partner, Morgan Flager. "Upon meeting Chad and Rita, we recognized Allthenticate's technology as having the potential to be paradigm-shifting for the industry. What the team has accomplished with modest financial resources to date is impressive. We are excited and honored to partner with Allthenticate to accelerate our shared vision of creating a safer and more secure world without passwords."

With the fresh funding, the company plans on growing its Houston team after Spensky relocated to Houston earlier this year. Allthenticate, which offices out of The Ion, is looking to grow within engineering, commercial operations, and partnerships.

"By the end of the year, we'll probably be at six people," Spensky previously told InnovationMap, adding that he hopes to pursue a series A round within the next 18 months.

The Allthenticate technology can be used to unlock everything from devices to doors. Photo courtesy of Allthenticate

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston space company lands latest NASA deal to advance lunar logistics

To The Moon

Houston-based space exploration, infrastructure, and services company Intuitive Machines has secured about $2.5 million from NASA to study challenges related to carrying cargo on the company’s lunar lander and hauling cargo on the moon. The lander will be used for NASA’s Artemis missions to the moon and eventually to Mars.

“Intuitive Machines has been methodically working on executing lunar delivery, data transmission, and infrastructure service missions, making us uniquely positioned to provide strategies and concepts that may shape lunar logistics and mobility solutions for the Artemis generation,” Intuitive Machines CEO Steve Altemus says in a news release.

“We look forward to bringing our proven expertise together to deliver innovative solutions that establish capabilities on the [moon] and place deeper exploration within reach.”

Intuitive Machines will soon launch its lunar lander on a SpaceX Falcon 9 rocket to deliver NASA technology and science projects, along with commercial payloads, to the moon’s Mons Mouton plateau. Lift-off will happen at NASA’s Kennedy Space Center in Florida within a launch window that starts in late February. It’ll be the lander’s second trip to the moon.

In September, Intuitive Machines landed a deal with NASA that could be worth more than $4.8 billion.

Under the contract, Intuitive Machines will supply communication and navigation services for missions in the “near space” region, which extends from the earth’s surface to beyond the moon.

The five-year deal includes an option to add five years to the contract. The initial round of NASA funding runs through September 2029.

Play it back: Houston home tech startup begins 2025 with fresh funding

HOUSTON INNOVATORS PODCAST EPISODE 272

One of the dozen or so Houston startups kicking of the new year with fresh funding is SmartAC.com, a company that's designed a platform that enables contractors in the HVAC and plumbing industries to monitor, manage, and optimize their maintenance memberships through advanced sensors, AI-driven diagnostics, and proactive alerts.

Last month, the SmartAC.com raised a follow-on round with support from local investor Mercury to continue growth and expansion of the product, which has evolved on many ways since the company launched in 2020, emerging from stealth with $10 million raised in a series A. In a May 2023 interview for the Houston Innovators Podcast, Founder and CEO Josh Teekell explained how he embraced the power of a pivot.

The company's sensors can monitor all aspects of air conditioning units and report back any issues, meaning homeowners have quicker and less costly repairs. While SmartAC.com started with providing the service and tech to homeowners directly, Teekell says he's had a greater interest in working with plumbers and HVAC companies who then deploy the technology to their customers.

"It became quite evident that homeowners don't care about air conditioning really at all until their system breaks," Teekell says on the show. "The technology is really built around giving those contractors as another way to gain a customer relationship and keep it."

Revisit the podcast episode below where Teekell talks about SmartAC.com's last raise.

SmartAC.com's previous round in 2023 — a $22 million series B — was used grow its team that goes out to deploy the technology and train the contractors on the platform.

"We've been very fortunate to get some of the biggest names in Houston on our cap table," Teekell says in the May 2023 conversation. "Since we're raising a bunch of money locally, everyone understands what a pain air conditioning can be."

Houston biotech company tests hard-to-fight cancer therapeutics

fighting cancer

A Houston-based, female-founded biotech company has developed a treatment that could prove to be an effective therapy for a rare blood cancer.

Cellenkos Therapeutics has completed promising Phase 1b testing of its Treg cell therapy, CK0804, in the fight against myelofibrosis. According to a news release from the Cellenkos team, the use of its cord-blood-derived therapeutics could signal a paradigm shift for the treatment of this hard-to-fight cancer.

Cellenkos was founded by MD Anderson Cancer Center physician and professor Simrit Parmar. Her research at the hospital displayed the ability of a unique subset of T cells’ capability to home in on a patient’s bone marrow, restoring immune balance, and potentially halting disease progression.

Myelofibrosis has long been treated primarily with JAK (Janus Kinase) inhibitors, medications that help to block inflammatory enzymes. They work by suppressing the immune response to the blood cancer, but don’t slow the progression of the malady. And they’re not effective for every patient.

“There is a significant need for new therapeutic options for patients living with myelofibrosis who have suboptimal responses to approved JAK inhibitors,” Parmar says. “We are greatly encouraged by the safety profile and early signs of efficacy observed in this patient cohort and look forward to continuing our evaluation of the clinical potential of CK0804 in our planned expansion cohort.”

The expansion cohort is currently enrolling patients with myelofibrosis. What exactly are sufferers dealing with? Myelofibrosis is a chronic disease that causes bone marrow to form scar tissue. This makes it difficult for the body to produce normal blood cells, leaving patients with fatigue, spleen enlargement and night sweats.

Myelofibrosis is rare, with just 16,000 to 18,500 people affected in the United States. But for patients who don’t respond well to JAKs, the prognosis could mean a shorter span than the six-year median survival rate outlined for the disease by Cleveland Clinic.

Helping myelofibrosis patients to thrive isn’t the only goal for Cellenkos right now.

The company seeks to aid people with rare conditions, particularly inflammatory and autoimmune disorders, with the use of CK0804, but also other candidates including one known as CK0801. The latter drug has shown promising efficacy in aplastic anemia, including transfusion independence in treated patients.

The company closed its $15 million series A round led by BVCF Management, based in Shanghai, in 2021. Read more here.